COMP <GO>
ZTS vs ROIV // NET PROFIT MARGIN
Zoetis Inc. (NYSE) VS. Roivant Sciences Ltd. (NASDAQ) • 15-METRIC TALLY: ZTS 9
— ROIV 2
▲ NET PROFIT MARGIN LEADER: ZTS
LAST: $83.18 (+4.34%) • MKT CAP: $32.94B
net-margins
28.20%
LAST: $35.89 (-2.76%) • MKT CAP: $26.66B
net-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZTS VS. ROIV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZTS | ROIV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 25.70% | -14.00% | +39.70 | ZTS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.01% | -2.80% | +9.81 | ZTS | /fcf-yield <GO> |
| Operating Margin | 34.40% | -60.00% | +94.40 | ZTS | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 28.20% | -60.00% | +88.20 | ZTS | /net-margins <GO> |
| Revenue Growth (YoY) | 2.30% | -65.00% | +67.30 | ZTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.53 | 26.00 | -21.47 | ROIV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 3/9 | +4.00 | ZTS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.6 | 53.3 | +6.30 | ZTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.00 | -0.01 | ROIV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.3x | 28.0x | -16.70 | ZTS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $32.94B | $26.66B | $6.28B | ZTS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZTS REV | ROIV REV | ZTS GROSS % | ROIV GROSS % | ZTS FCF | ROIV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.47B | $8.3M | 71.8% | — | $2.28B | -$758.6M |
| FY 2024 | $9.26B | $29.1M | 70.6% | — | $2.30B | -$844.0M |
| FY 2023 | $8.54B | $32.7M | — | — | $1.97B | -$766.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZTS // BETA 0.99
ROIV // BETA 1.00